Sabal Trust’s Idexx Laboratories IDXX Stock Holding History

Sabal Trust’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$1.05M	Buy	2,503 +539	+27%	+$234K	0.06%	143
2024 Q4	$812K	Buy	+1,964	New	+$861K	0.05%	163

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Sabal Trust's IDXX Position: Q1 2025 in Review

Sabal Trust increased its Idexx Laboratories (IDXX) stake by 27% in Q1 2025, buying an estimated $234K and bringing the position to 2,503 shares worth $1.05M. The position accounts for 0.06% of the portfolio, ranked #143.

Sabal Trust first reported a position in IDXX in Q4 2024 and has held it in 2 quarters since. 1,143 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

Sabal Trust held 2,503 shares of Idexx Laboratories worth $1.05M as of Q1 2025.
Sabal Trust bought 539 Idexx Laboratories shares in Q1 2025, an estimated $234K.
Idexx Laboratories made up 0.06% of Sabal Trust's portfolio in Q1 2025, its #143 holding.
Sabal Trust first reported a position in Idexx Laboratories in Q4 2024 and has held it in 2 quarters since.
1,143 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Sabal Trust's 13F filing for Q1 2025, filed 23 Apr 2025.